29 results
Monoclonal Antibodies: Update on this COVID-19 Experimental Therapy
https://discoverysedge.mayo.edu/2021/02/17/monoclonal-antibodies-update-on-this-covid-19-experimental-therapy/
Monoclonal Antibodies: Update on this COVID-19 Experimental Therapy ... experimental treatments for COVID-19 focus on two targets: the virus or the immune ... patients who are at risk of severe COVID-19 disease. These experimental drugs ... monoclonal antibody infusion to a COVID-19 positive person requires all the right ... intravenous (IV) infusion. New for COVID-19: Bamlanivimab and Etesevimab ToThe Importance of Antibody Testing in Addressing COVID-19
https://discoverysedge.mayo.edu/2020/04/03/the-importance-of-antibody-testing-in-addressing-covid-19/
of Antibody Testing in Addressing COVID-19 ... learned so far in the course of the COVID-19 pandemic, it's the important role ... SARS-CoV-2, the virus that causes COVID-19. These tests, known as polymerase ... parts of DNA. In the case of COVID-19 testing, the viral RNA is translated ... reveal whether a patient has had COVID-19, even if they were never diagnosedResearch into Experimental COVID-19 Therapeutics Explained
https://discoverysedge.mayo.edu/2020/10/03/research-into-experimental-covid-19-therapeutics-explained/
into Experimental COVID-19 Therapeutics Explained ... COVID-19 can affect people ... block it. The virus that causes COVID-19 is called SARS-CoV-2. It is in a family ... experimental use to treat severe COVID-19 on May 1, 2020. However, remdesivir’s ... development specifically for treatment of COVID-19. Immune System-Focused ExperimentalCOVID-19 Experimental Antibody Treatment Reaches Patients
https://discoverysedge.mayo.edu/2020/11/19/covid-19-experimental-antibody-treatment-reaches-patients/
COVID-19 Experimental Antibody Treatment Reaches Patients ... 19, Mayo Clinic began offering an experimental therapy to patients who test ... test positive for COVID-19 and are at high risk for serious illness. The therapy ... locations to minimize the effects of COVID-19 in a limited number of patients who ... SARS-CoV-2 virus, the virus that causes COVID-19. It is administered in an IV. TheConvalescent Plasma: A Therapy for COVID-19?
https://discoverysedge.mayo.edu/2020/04/06/convalescent-plasma-a-therapy-for-covid-19/
Therapy for COVID-19? ... To develop a treatment for patients with COVID-19, researchers ... SARS-CoV-2, the virus that causes COVID-19. Antibodies are a tool the body ... patients with severe or life-threatening COVID-19, or those at high risk of progression ... not yet known by which mechanism COVID-19 antibodies might work, but the thinkingMayo Clinic COVID-19 modeling for patients, communities
https://discoverysedge.mayo.edu/2020/06/16/mayo-clinic-covid-19-modeling-for-patients-communities/
Mayo Clinic COVID-19 modeling for patients, communities ... gotten a lot of airtime during the COVID-19 pandemic. Understanding both the virus ... Clinic's COVID-19 Data Governance Task Force, which oversees COVID-19 modeling ... Affordability team. Dr. Ting and the COVID-19 Data Governance Task Force are modeling ... Storlie, Ph.D., and their team, run COVID-19 predictive modeling programs to forecasthttps://discoverysedge.mayo.edu/2020/04/15/antibody-testing-in-pictures/
plasma therapy for the treatment of COVID-19 virus infection is based on the function ... test to diagnose their illness as COVID-19. The blood is processed to separate ... virus are present. Once COVID-19 antibodies are confirmed, the donor ... COVID-19COVID-19 Vaccines Use Different Attack Modes
https://discoverysedge.mayo.edu/2021/02/01/covid-19-vaccines-use-different-attack-modes/
COVID-19 Vaccines Use Different Attack Modes ... that causes COVID-19 continues to evolve, there are vaccines developed so far that ... that prevent severe COVID-19. However, they approach their goal ― a swift and ... is the spike proteins. One type of COVID-19 vaccine packages the spike protein ... response. The virus that causes COVID-19 is called SARS-CoV-2. It is in a family